News | July 03, 2012

FSS Announces CE Mark for its FlexStent Iliac Self Expanding Stent System

July 3, 2012 — Flexible Stenting Solutions Inc., a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced that it has extended its CE mark authorized family of peripheral vascular stents to include the FlexStent iliac self expanding stent system.

The FlexStent iliac self expanding stent system is indicated for the treatment of symptomatic atherosclerotic disease of the common and/or external iliac arteries. With this product line extension, the FlexStent family of peripheral vascular stent systems now includes stent diameters of 5, 6, 7, 8, 9 and 10 mm, and offers the physician additional options in the treatment of patients with peripheral artery disease (PAD) of the iliac, superficial femoral and popliteal arteries.

The addition of the FlexStent iliac self expanding stent system to the FSS CE mark authorized family of peripheral vascular stents enhances marketing opportunities for FSS products in the European medical device space. Market launch of the FlexStent iliac self expanding stent system in Europe is expected in Q3 2012.

As with the FlexStent femoropopliteal self expanding stent system, the FlexStent iliac self expanding stent system is an innovative, nearly fully connected, flexible, strong and durable nitinol stent delivered from a straightforward stent delivery system. In addition to simplicity and ease of use, the 6 French / .035" over the wire delivery system provides the physician with a means for very accurate stent deployment.

For more information: www.flexiblestent.com


Related Content

News | Peripheral Artery Disease (PAD)

Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...

Home November 08, 2024
Home
News | Peripheral Artery Disease (PAD)

Sept. 16, 2024 – Shockwave Medical, Inc., part of Johnson & Johnson MedTech, has announced the full U.S. launch of the ...

Home September 16, 2024
Home
News | Peripheral Artery Disease (PAD)

Sept. 1, 2024 — September is Peripheral Artery Disease (PAD) Awareness Month, a time to educate and empower people to ...

Home September 04, 2024
Home
News | Peripheral Artery Disease (PAD)

May 16, 2024 — Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care ...

Home May 16, 2024
Home
News | Peripheral Artery Disease (PAD)

May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...

Home May 08, 2024
Home
News | Peripheral Artery Disease (PAD)

March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug ...

Home March 20, 2024
Home
News | Peripheral Artery Disease (PAD)

February 12, 2024 — Sensome, a company pioneering the connected medical device revolution with the world’s smallest ...

Home February 12, 2024
Home
News | Peripheral Artery Disease (PAD)

November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for ...

Home November 10, 2023
Home
News | Peripheral Artery Disease (PAD)

October 24, 2023 — Four years ago, following a publication based on the limited data available, the U.S. Food and Drug ...

Home October 24, 2023
Home
News | Peripheral Artery Disease (PAD)

September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...

Home September 14, 2023
Home
Subscribe Now